20 results on '"Rowshani, A"'
Search Results
2. Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial
- Author
-
Marks, WH, Mamode, N. (Nizam), Montgomery, R.A., Stegall, M.D., Ratner, LE, Cornell, L.D., Rowshani, A.T. (Ajda), Colvin, R.B., Dain, B., Boice, J.A., Glotz, D., Marks, WH, Mamode, N. (Nizam), Montgomery, R.A., Stegall, M.D., Ratner, LE, Cornell, L.D., Rowshani, A.T. (Ajda), Colvin, R.B., Dain, B., Boice, J.A., and Glotz, D.
- Abstract
We report results of a phase 2, randomized, multicenter, open‐label, two‐arm study evaluating the safety and efficacy of eculizumab in preventing acute antibody‐ mediated rejection (AMR) in sensitized recipients of living‐donor kidney transplants requiring pretransplant desensitization (NCT01399593). In total, 102 patients under‐ went desensitization. Posttransplant, 51 patients received standard of care (SOC) and 51 received eculizumab. The primary end point was week 9 posttransplant treat‐ ment failure rate, a composite of: biopsy‐proven acute AMR (Banff 2007 grade II or III; assessed by blinded central pathology); graft loss; death; or loss to follow‐up. Eculizumab was well tolerated with no new safety concerns. No significant difference in treatment failure rate was observed between eculizumab (9.8%) and SOC (13.7%; P = .760). To determine whether data assessment assumptions affected study out‐ come, biopsies were reanalyzed by central pathologists using clinical information. The resulting treatment failure rates were 11.8% and 21.6% for the eculizumab and SOC groups, respectively (nominal P = .288). When reassessment included grade I AMR, the treatment failure rates were 11.8% (eculizumab) and 29.4% (SOC; nominal P = .048). This finding suggests a potential benefit for eculizumab compared with SOC in preventing acute AMR in recipients sensitized to their living‐donor kidney transplants (EudraCT 2010‐019630‐28).
- Published
- 2019
- Full Text
- View/download PDF
3. Pharmacodynamic Monitoring of Tacrolimus-based Immunosuppression in CD14+ Monocytes after Kidney Transplantation
- Author
-
Kannegieter, N.M. (Nynke), Hesselink, D.A. (Dennis), Dieterich, M. (Marjolein), Graav, G.N. (Gretchen) de, Kraaijeveld, R. (Rens), Rowshani, A.T. (Ajda), Leenen, P.J.M. (Pieter), Baan, C.C. (Carla), Kannegieter, N.M. (Nynke), Hesselink, D.A. (Dennis), Dieterich, M. (Marjolein), Graav, G.N. (Gretchen) de, Kraaijeveld, R. (Rens), Rowshani, A.T. (Ajda), Leenen, P.J.M. (Pieter), and Baan, C.C. (Carla)
- Abstract
Background: Monocytes significantly contribute to ischemia-reperfusion injury and allograft rejection after kidney transplantation. However, the knowledge about the effects of immunosuppressive drugs on monocyte activation is limited. Conventional pharmacokinetic methods for immunosuppressive drug monitoring are not cell type–specific. In this study, phosphorylation of 3 signaling proteins was measured to determine the pharmacodynamic effects of immunosuppression on monocyte activation in kidney transplant patients. Methods: Blood samples from 20 kidney transplant recipients were monitored before and during the first year after transplantation. All patients received induction therapy with basiliximab, followed by tacrolimus (TAC), mycophenolate mofetil, and prednisolone maintenance therapy. TAC whole-blood predose concentrations were determined using an antibody-conjugated magnetic immunoassay. Samples were stimulated with phorbol 12-myristate 13-acetate (PMA)/ionomycin, and phosphorylation of p38MAPK, ERK, and Akt in CD14+ monocytes was quantified by phospho-specific flow cytometry. Results: Phosphorylation of p38MAPK and Akt in monocytes of immunosuppressed recipients was lower after 360 days compared with before transplantation in the unstimulated samples [mean reduction in median fluorescence intensity 36%; range −28% to 77% for p-p38MAPK and 20%; range −22% to 53% for p-Akt; P < 0.05]. P-ERK was only decreased at day 4 after transplantation (mean inhibition 23%; range −52% to 73%; P < 0.05). At day 4, when the highest whole-blood predose TAC concentrations were measured, p-p38MAPK and p-Akt, but not p-ERK, correlated inversely with TAC (rs = −0.65; P = 0.01 and rs = −0.58; P = 0.03, respectively). Conclusions: Immunosuppressive drug combination therapy partially inhibits monocyte activation pathways after kidney transplantation. This inhibition can be determined by phospho-specific flow cytometry, which enables the assessment of the pharmacodynamic effects of i
- Published
- 2017
- Full Text
- View/download PDF
4. Targeting the monocyte-macrophage lineage in solid organ transplantation
- Author
-
Bosch, T.P.P. (Thierry) van den, Kannegieter, N.M. (Nynke), Hesselink, D.A. (Dennis), Baan, C.C. (Carla), Rowshani, A.T. (Ajda), Bosch, T.P.P. (Thierry) van den, Kannegieter, N.M. (Nynke), Hesselink, D.A. (Dennis), Baan, C.C. (Carla), and Rowshani, A.T. (Ajda)
- Abstract
There is an unmet clinical need for immunotherapeutic strategies that specifically target the active immune cells participating in the process of rejection after solid organ transplantation. The monocyte-macrophage cell lineage is increasingly recognized as a major player in acute and chronic allograft immunopathology. The dominant presence of cells of this lineage in rejecting allograft tissue is associated with worse graft function and survival. Monocytes and macrophages contribute to alloimmunity via diverse pathways: antigen processing and presentation, costimulation, pro-inflammatory cytokine production, and tissue repair. Cross talk with other recipient immune competent cells and donor endothelial cells leads to amplification of inflammation and a cytolytic response in the graft. Surprisingly, little is known about therapeutic manipulation of the function of cells of the monocyte-macrophage lineage in transplantation by immunosuppressive agents. Although not primarily designed to target monocyte-macrophage lineage cells, multiple categories of currently prescribed immunosuppressive drugs, such as mycophenolate mofetil, mammalian target of rapamycin inhibitors, and calcineurin inhibitors, do have limited inhibitory effects. These effects include diminishing the degree of cytokine production, thereby blocking costimulation and inhibiting the migration of monocytes to the site of rejection. Outside the field of transplantation, some clinical studies have shown that the monoclonal antibodies canakinumab, tocilizumab, and infliximab are effective in inhibiting monocyte functions. Indirect effects have also been shown for simvastatin, a lipid lowering drug, and bromodomain and extra-terminal motif inhibitors that reduce the cytokine production by monocytes-macrophages in patients with diabetes mellitus and rheumatoid arthritis. To date, detailed knowledge concerning the origin, the developmental requirements, and functions of diverse specialized monocyte-macrophage
- Published
- 2017
- Full Text
- View/download PDF
5. Pretransplant Numbers of CD16(+) Monocytes as a Novel Biomarker to Predict Acute Rejection After Kidney Transplantation: A Pilot Study
- Author
-
Bosch, T.P.P. van den, Hilbrands, L.B., Kraaijeveld, R., Litjens, N.H., Rezaee, F., Nieboer, D., Steyerberg, E.W., Gestel, J.A. van, Roelen, D.L., Groningen, M.C. Clahsen-van, Baan, C.C., Rowshani, A.T., Bosch, T.P.P. van den, Hilbrands, L.B., Kraaijeveld, R., Litjens, N.H., Rezaee, F., Nieboer, D., Steyerberg, E.W., Gestel, J.A. van, Roelen, D.L., Groningen, M.C. Clahsen-van, Baan, C.C., and Rowshani, A.T.
- Abstract
Item does not contain fulltext, Acute rejection is one of the major immunological determinants of kidney graft function and survival. Early biomarkers to predict rejection are lacking. Emerging evidence reveals a crucial role for the monocyte/macrophage lineage cells in the pathogenesis of rejection. We hypothesized that higher pretransplant numbers of proinflammatory CD16+ monocytes can predict rejection. The study cohort consisted of 104 kidney transplant recipients (58 with no rejection and 46 with biopsy-proven rejection) and 33 healthy persons. Posttransplant median follow-up time was 14.7 mo (interquartile range 0.3-34 mo). Pretransplantation blood samples were analyzed by flow cytometry for monocyte immunophenotypes. Groups were compared by Cox regression models for the occurrence of acute rejection. We documented a significantly increased absolute number of pretransplant CD16+ monocytes in patients who developed biopsy-proven rejection after transplantation compared with those with no rejection (hazard ratio [HR] 1.60, 95% CI 1.28-2.00, p < 0.001) and healthy persons (HR 1.47, 95% CI 1.18-1.82, p < 0.001). In parallel, significantly fewer absolute numbers of CD16- monocytes were observed at pretransplant time points in rejectors versus nonrejectors (HR 0.74, 95% CI 0.58-0.94, p < 0,014). A higher pretransplant number of CD16+ monocytes is significantly associated with a higher risk of acute rejection after kidney transplantation.
- Published
- 2017
6. Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14(+) Monocytes After Kidney Transplantation
- Author
-
Kannegieter, Nynke, Hesselink, Dennis, Marijnissen - Dieterich, Marjolein, Graav, Gretchen, Kraaijeveld, Rens, Rowshani, AT, Leenen, Pieter, Baan, Carla, Kannegieter, Nynke, Hesselink, Dennis, Marijnissen - Dieterich, Marjolein, Graav, Gretchen, Kraaijeveld, Rens, Rowshani, AT, Leenen, Pieter, and Baan, Carla
- Published
- 2017
7. Targeting the Monocyte-Macrophage Lineage in Solid Organ Transplantation
- Author
-
van den Bosch, Thierry, Kannegieter, Nynke, Hesselink, Dennis, Baan, Carla, Rowshani, Ajda, van den Bosch, Thierry, Kannegieter, Nynke, Hesselink, Dennis, Baan, Carla, and Rowshani, Ajda
- Published
- 2017
8. CD16+Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection
- Author
-
van den Bosch, Thierry, Caliskan, Kadir, Kraaij, Marina, Constantinescu, Alina, Manintveld, Olivier, Leenen, Pieter, von der Thüsen, Jan, Clahsen - van Groningen, Marian, Baan, Carla, Rowshani, Ajda, van den Bosch, Thierry, Caliskan, Kadir, Kraaij, Marina, Constantinescu, Alina, Manintveld, Olivier, Leenen, Pieter, von der Thüsen, Jan, Clahsen - van Groningen, Marian, Baan, Carla, and Rowshani, Ajda
- Published
- 2017
9. The Effect of Tacrolimus and Mycophenolic Acid on CD14+Monocyte Activation and Function
- Author
-
Kannegieter, Nynke, Hesselink, Dennis, Marijnissen - Dieterich, Marjolein, Kraaijeveld, Rens, Rowshani, Ajda, Leenen, Pieter, Baan, Carla, Kannegieter, Nynke, Hesselink, Dennis, Marijnissen - Dieterich, Marjolein, Kraaijeveld, Rens, Rowshani, Ajda, Leenen, Pieter, and Baan, Carla
- Published
- 2017
10. Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells
- Author
-
Demmers, M.W.H.J., Korevaar, S.S., Betjes, M.G., Weimar, W., Rowshani, A.T., Baan, C.C., Demmers, M.W.H.J., Korevaar, S.S., Betjes, M.G., Weimar, W., Rowshani, A.T., and Baan, C.C.
- Abstract
Item does not contain fulltext
- Published
- 2015
11. Lipid droplets hypertrophy: a crucial determining factor in insulin regulation by adipocytes.
- Author
-
Sanjabi, B., Dashty, M., Ozcan, B., Akbarkhanzadeh, V., Rahimi, M., Vinciguerra, M., Rooij, F. van, Al-Lahham, S., Sheedfar, F., Kooten, T.G. van, Spek, C.A., Rowshani, A.T., Want, J. van der, Klaassen, R., Sijbrands, E., Peppelenbosch, M.P., Rezaee, F., Sanjabi, B., Dashty, M., Ozcan, B., Akbarkhanzadeh, V., Rahimi, M., Vinciguerra, M., Rooij, F. van, Al-Lahham, S., Sheedfar, F., Kooten, T.G. van, Spek, C.A., Rowshani, A.T., Want, J. van der, Klaassen, R., Sijbrands, E., Peppelenbosch, M.P., and Rezaee, F.
- Abstract
Contains fulltext : 153283.pdf (publisher's version ) (Open Access), Lipid droplets (LDs) hypertrophy in adipocytes is the main cause of energy metabolic system dysfunction, obesity and its afflictions such as T2D. However, the role of adipocytes in linking energy metabolic disorders with insulin regulation is unknown in humans. Human adipocytes constitutively synthesize and secrete insulin, which is biologically functional. Insulin concentrations and release are fat mass- and LDs-dependent respectively. Fat reduction mediated by bariatric surgery repairs obesity-associated T2D. The expression of genes, like PCSK1 (proinsulin conversion enzyme), GCG (Glucagon), GPLD1, CD38 and NNAT, involved in insulin regulation/release were differentially expressed in pancreas and adipose tissue (AT). INS (insulin) and GCG expression reduced in human AT-T2D as compared to AT-control, but remained unchanged in pancreas in either state. Insulin levels (mRNA/protein) were higher in AT derived from prediabetes BB rats with destructed pancreatic beta-cells and controls than pancreas derived from the same rats respectively. Insulin expression in 10 human primary cell types including adipocytes and macrophages is an evidence for extrapancreatic insulin-producing cells. The data suggest a crosstalk between AT and pancreas to fine-tune energy metabolic system or may minimize the metabolic damage during diabetes. This study opens new avenues towards T2D therapy with a great impact on public health.
- Published
- 2015
12. Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus
- Author
-
Demmers, M.W.H.J., Baan, C.C., Janssen, M, Litjens, N.H., Ijzermans, J.N., Betjes, M.G., Weimar, W., Rowshani, A.T., Demmers, M.W.H.J., Baan, C.C., Janssen, M, Litjens, N.H., Ijzermans, J.N., Betjes, M.G., Weimar, W., and Rowshani, A.T.
- Abstract
Item does not contain fulltext
- Published
- 2015
13. Lipid droplets hypertrophy: A crucial determining factor in insulin regulation by adipocytes
- Author
-
Sanjabi, B. (Bahram), Dashty, M. (Monireh), Özcan, B. (Behiye), Akbarkhanzadeh, V. (Vishtaseb), Rahimi, M. (Mehran), Vinciguerra, M. (Manlio), Rooij, F. (Felix) van, Al-Lahhman, S.H. (Sa'ad), Sheedfar, F. (Fareeba), Van Kooten, T.G. (Theo G.), Spek, C.A. (Arnold), Rowshani, A.T. (Ajda), Want, J.J.L. (Johannes) van der, Klaassen, R. (Rene), Sijbrands, E.J.G. (Eric), Peppelenbosch, M.P. (Maikel), Rezaee, F. (Farhad), Sanjabi, B. (Bahram), Dashty, M. (Monireh), Özcan, B. (Behiye), Akbarkhanzadeh, V. (Vishtaseb), Rahimi, M. (Mehran), Vinciguerra, M. (Manlio), Rooij, F. (Felix) van, Al-Lahhman, S.H. (Sa'ad), Sheedfar, F. (Fareeba), Van Kooten, T.G. (Theo G.), Spek, C.A. (Arnold), Rowshani, A.T. (Ajda), Want, J.J.L. (Johannes) van der, Klaassen, R. (Rene), Sijbrands, E.J.G. (Eric), Peppelenbosch, M.P. (Maikel), and Rezaee, F. (Farhad)
- Abstract
Lipid droplets (LDs) hypertrophy in adipocytes is the main cause of energy metabolic system dysfunction, obesity and its afflictions such as T2D. However, the role of adipocytes in linking energy metabolic disorders with insulin regulation is unknown in humans. Human adipocytes constitutively synthesize and secrete insulin, which is biologically functional. Insulin concentrations and release are fat mass-and LDs-dependent respectively. Fat reduction mediated by bariatric surgery repairs obesity-associated T2D the expression of genes, like PCSK1 (proinsulin conversion enzyme), GCG (Glucagon), GPLD1, CD38 and NNAT, involved in insulin regulation/release were differentially expressed in pancreas and adipose tissue (AT). INS (insulin) and GCG expression reduced in human AT-T2D as compared to AT-control, but remained unchanged in pancreas in either state. Insulin levels (mRNA/protein) were higher in AT derived from prediabetes BB rats with destructed pancreatic 2-cells and controls than pancreas derived from the same rats respectively. Insulin expression in 10 human primary cell types including adipocytes and macrophages is an evidence for extrapancreatic insulin-producing cells the data suggest a crosstalk between AT and pancreas to fine-tune energy metabolic system or may minimize the metabolic damage during diabetes. This study opens new avenues towards T2D therapy with a great impact on public health.
- Published
- 2015
- Full Text
- View/download PDF
14. A Shift towards Pro-Inflammatory CD16+Monocyte Subsets with Preserved Cytokine Production Potential after Kidney Transplantation
- Author
-
Vereyken, Elly, Kraaij, Marina, Baan, Carla, Rezaee, Farhad, Weimar, Willem, Wood, KJ, Leenen, Pieter, Rowshani, Ajda, Vereyken, Elly, Kraaij, Marina, Baan, Carla, Rezaee, Farhad, Weimar, Willem, Wood, KJ, Leenen, Pieter, and Rowshani, Ajda
- Abstract
Background: The presence of monocyte-macrophage lineage cells in rejecting kidney transplants is associated with worse graft outcome. At present, it is still unclear how the monocyte-macrophage related responses develop after transplantation. Here, we studied the dynamics, phenotypic and functional characteristics of circulating monocytes during the first 6 months after transplantation and aimed to establish the differences between kidney transplant recipients and healthy individuals. Methods: Phenotype, activation status and cytokine production capacity of classical (CD14++CD16-), intermediate (CD14++CD16+) and non-classical (CD14+CD16++), monocytes were determined by flow cytometry in a cohort of 33 healthy individuals, 30 renal transplant recipients at transplantation, 19 recipients at 3 months and 16 recipients at 6 months after transplantation using a cross-sectional approach. Results: The percentage of both CD16+ monocyte subsets was significantly increased in transplant recipients compared to healthy individuals, indicative of triggered innate immunity (p <= 0.039). Enhanced production capacity of tumor necrosis factor-alpha, interferon-gamma and interleukin-1 beta was observed by monocytes at transplantation compared to healthy individuals. Remarkably, three months post-transplant, in presence of potent immunosuppressive drugs and despite improved kidney function, Conclusion: Our data demonstrate a skewed balance towards pro- inflammatory CD16+ monocytes that is present at the time of transplantation and retained for at least 6 months after transplantation. This shift could be one of the important drivers of early post-transplant cellular immunity.
- Published
- 2013
15. Differential Effects of Activated Human Renal Epithelial Cells on T-Cell Migration
- Author
-
Demmers, Martijn, Baan, Carla, van Beelen, E, IJzermans, J.N.M., Weimar, Willem, Rowshani, Ajda, Demmers, Martijn, Baan, Carla, van Beelen, E, IJzermans, J.N.M., Weimar, Willem, and Rowshani, Ajda
- Abstract
Background: Renal tubular epithelial cells (TECs) are one of the main targets of inflammatory insults during interstitial nephritis and kidney transplant rejection. While Th1 cells are know to be essential in the pathogenesis of rejection, the role of Th17 is still under debate. We hypothesize that TECs modulate the outcome of rejection process by production of distinct chemokines and cytokines that determine the attraction of different T-cell subsets. Therefore, we studied differential effects of activated human renal epithelial cells on T-cell migration. Methods: Human primary TECs were stimulated by IFN-gamma and TNF-alpha in vitro. Chemokines and cytokines produced by activated TECs were measured using Luminex or ELISA. Chemotaxis assay was performed using activated peripheral blood mononuclear cells composed of CD4(+)CXCR3(+) and CD4(+)CCR6(+) T cells migrating towards stimulated and unstimulated TECs. Results: While activated TECs secreted abundant amounts of the pro-inflammatory cytokines IL-6 and IL-8, the T helper cell differentiation cytokines IL-1 beta, IL-12p70, IL-23 or TGF-beta 1 were not produced. The production of Th1 chemokines CXCL9, CXCL10 and CCL5 were significantly upregulated after TEC stimulation. In contrast, Th17 chemokine CCL20 could not be detected. Finally, activated TECs attracted significantly higher numbers of CD4(+)CXCR3(+) T cells as compared to unstimulated TECs. N Conclusion: Activated primary renal tubular epithelial cells do not attract Th17 cells nor produce cytokines promoting Th17 cell differentiation in our experimental system mimicking the proinflammatory microenvironment of rejection.
- Published
- 2013
16. SerpinB9 expression in human renal tubular epithelial cells is induced by triggering of the viral dsRNA sensors TLR3, MDA5 and RIG-I.
- Author
-
Heutinck, K.M., Kassies, J., Florquin, S., Berge, I.J. Ten, Hamann, J., Rowshani, A.T., Heutinck, K.M., Kassies, J., Florquin, S., Berge, I.J. Ten, Hamann, J., and Rowshani, A.T.
- Abstract
1 juli 2012, Item does not contain fulltext, Background Serine protease inhibitor B9 (serpinB9) protects against granzyme B-mediated apoptosis and could help to reduce tubular damage under inflammatory conditions like interstitial nephritis. Previously, we found that tubular serpinB9 expression was increased during subclinical rejection. Here, we studied the regulation of serpinB9 expression in tubular epithelial cells (TECs) under inflammatory conditions. Methods SerpinB9 expression was analysed on messenger RNA (mRNA), and protein levels in primary human TECs were stimulated with various cytokines and pattern recognition receptor ligands and in kidney transplant biopsies obtained during different types of viral infection. Results Of the inflammatory stimuli tested, only the double-stranded RNA (dsRNA) analogue poly(I:C) promoted serpinB9 mRNA and protein expression. We found that TECs express the viral dsRNA receptors Toll-like receptor 3 (TLR3), melanoma differentiation-associated gene 5 (MDA5) and retinoic acid-inducible gene-I (RIG-I). dsRNA receptor ligands enhanced serpinB9 expression, which involved nuclear factor-kappaB (NF-kappaB) activation, did not require Type I interferon production and was a direct result of dsRNA receptor-induced gene transcription. In kidney transplants, serpinB9 transcription was increased during infection with cytomegalovirus, Epstein-Barr virus or BK virus compared to stable grafts. Immunohistochemistry showed that tubuli and lymphocytes expressed the inhibitor. Conclusion SerpinB9 expression in human TECs is induced by triggering of the viral dsRNA sensors TLR3, MDA5 and RIG-I. Viral dsRNA may increase the threshold for granzyme B-mediated apoptosis in TECs via serpinB9 upregulation and thus help to protect the kidney against cytotoxic insults during viral infection.
- Published
- 2012
17. Viral double-stranded RNA sensors induce antiviral, pro-inflammatory, and pro-apoptotic responses in human renal tubular epithelial cells
- Author
-
Heutinck, K.M., Rowshani, A.T., Kassies, J., Claessen, N., van Donselaar-van der Pant, K.A., Bemelman, F.J., Eldering, E., van Lier, R.A., Florquin, S., Ten Berge, I.J., Hamann, J., Heutinck, K.M., Rowshani, A.T., Kassies, J., Claessen, N., van Donselaar-van der Pant, K.A., Bemelman, F.J., Eldering, E., van Lier, R.A., Florquin, S., Ten Berge, I.J., and Hamann, J.
- Abstract
Item does not contain fulltext, Viral infection in the kidney is characterized by tubular injury induced directly by the virus and/or by cytotoxic lymphocytes. Previously, we found that human tubular epithelial cells express Toll-like receptor 3 (TLR3), melanoma differentiation-associated gene 5 (MDA5), and retinoic acid-inducible gene-I (RIG-I), all sensors of double-stranded RNA (dsRNA) and potent inducers of antiviral activity. Here, we demonstrate increased expression of these three dsRNA sensors in kidney transplant biopsies during cytomegalovirus or BK virus infection. In primary tubular epithelial cells, dsRNA sensor activation induced the production of pro-inflammatory TNF-alpha and antiviral IFN-beta. Notably, dsRNA also enhanced the expression of pro-apoptotic proteins; however, dsRNA alone did not cause cell death due to the expression of anti-apoptotic proteins. The dsRNA sensitized tubular epithelial cells to apoptosis induced by an agonistic antibody against the Fas receptor (CD95), an apoptotic pathway that eliminates infected cells. These findings indicate that tubular epithelial cells require at least two signals to undergo apoptosis, which can help preserve tubular integrity even under inflammatory conditions. Thus, sensors of viral dsRNA promote antiviral, pro-inflammatory, and pro-apoptotic responses in tubular epithelial cells, which may orchestrate the control of viral infection in the kidney.
- Published
- 2012
18. FoxP3 cells and the pathophysiologic effects of brain death and warm ischemia in donor kidneys
- Author
-
Baan, Carla, Peeters, Annemiek, Demmers, Martijn, Mol, WM, Boer, Karin, Samsom, Janneke, Rowshani, AT, IJzermans, J.N.M., Weimar, Willem, Baan, Carla, Peeters, Annemiek, Demmers, Martijn, Mol, WM, Boer, Karin, Samsom, Janneke, Rowshani, AT, IJzermans, J.N.M., and Weimar, Willem
- Published
- 2012
19. Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT)
- Author
-
Hoogduijn, Martin Johannes, Rabelink, Ton Johannes, Van Der Laan, Luc J W, Dor, Frank J M F F.J.M.F., Ijzermans, Jan J.N.M., Genever, Paul P.G., Lange, Claudia, Durrbach, Antoine, Houtgraaf, Jaco J.H., Christ, Bruno, Seifert, Martina, Popp, Felix Cristoph, Shagidulin, Murat, Donckier De Donceel, Vincent, Deans, Robert, Ringden, Olle, Perico, Norberto, Remuzzi, Giuseppe, Bartholomew, Amelia, Schlitt, Hans Jürgen ürgen H.J., Weimar, Willem, Baan, Carla C.C., Grohnert, Anja, Dahlke, Marc Hendrik, Crop, Meindert Johannes, Van Rhijn, Marieke, Rowshani, Ajda Tahereh, Eggenhofer, Elke, Renner, Philipp, Reinders, Marlies E J M.E., Hoogduijn, Martin Johannes, Rabelink, Ton Johannes, Van Der Laan, Luc J W, Dor, Frank J M F F.J.M.F., Ijzermans, Jan J.N.M., Genever, Paul P.G., Lange, Claudia, Durrbach, Antoine, Houtgraaf, Jaco J.H., Christ, Bruno, Seifert, Martina, Popp, Felix Cristoph, Shagidulin, Murat, Donckier De Donceel, Vincent, Deans, Robert, Ringden, Olle, Perico, Norberto, Remuzzi, Giuseppe, Bartholomew, Amelia, Schlitt, Hans Jürgen ürgen H.J., Weimar, Willem, Baan, Carla C.C., Grohnert, Anja, Dahlke, Marc Hendrik, Crop, Meindert Johannes, Van Rhijn, Marieke, Rowshani, Ajda Tahereh, Eggenhofer, Elke, Renner, Philipp, and Reinders, Marlies E J M.E.
- Abstract
There is evolving interest in the use of mesenchymal stem cells (MSC) in solid organ transplantation. Pre-clinical transplantation models show efficacy of MSC in prolonging graft survival and a number of clinical studies are planned or underway. At a recent meeting of the MISOT consortium (MSC In Solid Organ Transplantation) the advances of these studies were evaluated and mechanisms underlying the potential effects of MSC discussed. Continued discussion is required for definition of safety and eventually efficacy endpoints for MSC therapy in solid organ transplantation. © 2010 by Lippincott Williams & Wilkins., SCOPUS: sh.j, info:eu-repo/semantics/published
- Published
- 2010
20. Cobertura de la lengua y cuentas bacterianas salivares en sujetos sanos y con gingivitis y en pacientes con periodontitis
- Author
-
Mantilla G., Sergio, Danser, Monique M., Sipos, Pali, Rowshani, Baherah, Van der Velden, Ubele, Van der Weijden, Fridus A., Mantilla G., Sergio, Danser, Monique M., Sipos, Pali, Rowshani, Baherah, Van der Velden, Ubele, and Van der Weijden, Fridus A.
- Abstract
Purpose: The purpose of this study was to investigate the discoloration and coating of the tongue in healthy/gingivitis subjects and periodontitis patients. Furthermore, to determine the relationship between the appearance of the tongue and the bacterial load in salivary samples.Material and Methods: Two groups of patients were studied, 70 healthy/gingivitis subjects and 56 periodontitis patients. After scoring of the tongue a salivary sample of each patient was taken and analyzed using a phase-contrast microscope.Results: This investigation showed that most discoloration was found on the distal part of the tongue. The mean number of bacteria per ml sample in relation to a pink, white and yellow appearance of the tongue was 948, 855 and 900 (x106) respectively. The mean number of bacteria per ml sample in relation to no, thin, and thick coating was 948, 863 and 895 (x106) respectively. Analysis did not reveal a relationship between discoloration, coating thickness and total bacterial load. The mean number of bacteria per ml in healthy/gingivitis subjects was 860 and in periodontitis patients 918 (x106).Conclusion: No relationship between the appearance of the tongue and salivary bacterial load could be detected. There was no difference in bacterial load between the healthy/gingivitis and the periodontitis group within the present study population., Objetivo: Investigar la coloración y la cobertura de la lengua en sujetos sanos y con gingivitis y en pacientes con periodontitis y determinar la relación entre la apariencia de la lengua y la carga bacteriana en muestras de saliva.Materiales y Métodos: Se estudiaron dos grupos de pacientes, 70 sujetos sanos y con gingivitis y 56 pacientes con periodontitis. Después de clasificar la lengua se tomó una muestra de saliva de cada paciente; ésta fue analizada usando un microscopio de contraste de fase.Resaltados: Los resultados mostraron que la mayoría de la coloración se encontró en la parte distal de lengua. El número promedio de bacterias por ml de muestra, en relación con una apariencia rosada, blanca y amarilla de la lengua, fue de 948, 855 y 900 (x 106) respectivamente. El número promedio de bacterias por ml de muestra en relación con no-cobertura, a una cobertura delgada y a una gruesa, fue de 948, 863 y 895 (x 106) respectivamente. No se encontró relación entre la coloración, grosor de cobertura y carga bacteriana total. El número promedio de bacterias por ml de muestra en sujetos sanos y con gingivitis fue de 860 y en pacientes con periodontitis, de 918 (x 106).Conclusiones: No se encontró relación entre la apariencia de la lengua y la carga bacteriana salivar. No hubo diferencia en carga bacteriana entre los grupos sanos y con gingivitis y el grupo con periodontitis en la población de estudio.[Mantilla S. Danser MM, Sipos P, Rowshani B, Van der Velden U, Van der Weijden F. Cobertura de la lengua y cuentas bacterianas salivares en sujetos sanos y con gingivitis y en pacientes con periodontitis. Ustasalud 2002; 1: 7 - 17]
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.